Beta-chemokine, macrophage inflammatory protein-1β (MIP-1β), is highly expressed in diffuse type human gastric cancers

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 3, 2003, Pages 453-459

  Saito, S ^a   Kitayama, J ^a   Jin, Z X ^a   Tsuno, N ^b   Kaisaki, S ^a   Seto, Y ^c   Nagawa, H ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Nakadori Hospital   (Japan)

Author keywords

Chemokine; Differentiation; Gastric cancer; Invasion; Macrophage inflammatory protein 1

Indexed keywords

BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ARTICLE; CANCER INVASION; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STAINING; STOMACH CANCER; TISSUE DISTRIBUTION; TUMOR DIFFERENTIATION;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MACROPHAGE INFLAMMATORY PROTEIN-1; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 0141447428     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Baggiolini M., Dewald B., and Moser B.: Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55; 97-179, 1994.
2. Rollins B.J.: Chemokines. Blood 90; 909-929, 1997.
3. Selvan R.S., Butterfield J.H., and Krangel M.S.: Expression of multiple chemokine genes by a human mast cell leukemia. J. Biol. Chem. 269;13893-13898, 1994.
4. Yang S.K., Eckmann L., Panja A., and Kagnoff M.F.: Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterol. 113; 1214-1223, 1997.
5. Schadendorf D., Moller A., Algermissen B., Worm M., Sticherling M., and Czametzki B.M.: IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151; 2667-2675, 1993.
6. Melani C., Pupa S.M., Stoppacciaro A., Menard S., Colnaghi M.I., Parmiani G., and Colombo M.P.: An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int. J. Cancer 62; 572-578, 1995.
7. Wood L.D. and Richmond A.: Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/Gro-α gene requires both NF-kB and novel constitutive factors. J. Biol. Chem 270; 30619-30626, 1995.
8. Francia di Celle P., Mariani S., Riera L., Stacchini A., Reato G., and Foa R.: Interleukin-8 induces the accumulation of B cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87; 4382-4389, 1996.
9. Miyamoto M., Shimizu Y., Okada K., Kashii Y., Higuchi K., and Watanabe A.: Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol. Innunother. 47; 47-57, 1998.
10. Eckmann L., Jung H.C., Schurer-Maly C., Panja A., Morzycka-Wroblewska E., and Kagnoff M.F.: Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin-8. Gastroenterol. 105; 1689-1697, 1993.
11. Wolpe S.D., Davatelis G., Sherry B., Beutler B., Hesse D.G., Nguyen H.T., Moldawer L.L., Nathan C.F., Lowry S.F., and Cerami A.: Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167; 570-581, 1988.
12. Graham G.J., Wright E.G., Hewick R., Wolpe S.D., Wilkie N.M., Donaldson D., Lorimore S., and Pragnell I.B.: Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344; 442-444, 1990.
13. Uguccioni M., D'Apuzzo M., Loetscher M., Dewald B., and Baggiolini M.: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur. J. Immunol. 25; 64-68, 1995.
14. Fahey T.J.,III, Tracey K.J., Tekamp-Olson P., Cousens L.S., Jones W.G., Shires G.T., Cerami A., and Sherry B.: Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148; 2764-2769, 1992.
15. Taub D.D., Conlon K., Lloyd A.R., Oppenheim J.J., and Kelvin D.J.: Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 260; 355-358, 1993.
16. Schall T.J., Bacon K., Camp R.D.R., Kaspari J.W., and Goeddel D.V.: Human macrophage inflammatory protein a (MIP-1α and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177; 1821-1825, 1993.
17. Roth S.J., Diacovo T.G., Brenner M.B., Rosat J.P., Buccola J., Morita C.T., and Springer T.A.: Transendothelial chemotaxis of human alpha/beta and gamma/delta T lymphocytes to chemokines. Eur. J. Immunol. 28; 104-113, 1998.
18. Murphy W.J., Tian Z.G., Asai O., Funakoshi S., Rotter P., Henry M., Strieter R.M., Kunkel S.L., Longo, D.L., and Taub D.D.: Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J. Immunol. 156; 2104-2111, 1996.
19. Dahinden C.A., Geiser T., Brunner T., von Tschamer V., Caput D., Ferrara P., Minty A., and Baggiolini M.: Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 179; 751-756, 1994.
20. Rot A., Krieger M., Brunner T., Bischoff S.C., Schall T.J., and Dahinden C.A.: RANTES and macrophage inflammatory protein 1a induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176; 1489-1495, 1992.
21. Alam R., Forsythe P.A., Stafford S., Lett-Brown M.A., and Grant J.A.: Macrophage inflammatory protein-1a activates basophils and mast cells. J. Exp. Med. 176; 781-786, 1992.
22. Loetscher P., Seitz M., Clark-Lewis I., Baggiolini M., and Moser B.: Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J. Immunol. 156; 322-330, 1996.
23. Taub D.D., Sayers T.J., Carter C.R., and Ortaldo J.R.: Alpha and beta chemokines induce NK cell migration and NK -mediated cytolysis. J. Immunol. 155; 3877-3885, 1995.
24. Sozzani S., Sullusto F., Luini W., Zhou D., Piemonti L., Allavena P., Van Dalme J., Valitutti S., Lanzavecchia A., and Mantovani A.: Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol 155; 3292-3298, 1995.
25. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., and Shaw S.: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361; 79-82, 1993.
26. Lloyd A.R., Oppenheim J.J., Kelvin D.J., and Taub D.D.: Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immunol. 156; 932-938, 1996.
27. Carr M.W., Alon R., and Springer T.A.: The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity 4; 179-187, 1996.
28. Taub D.D., Ortaldo J.R., Turcovski-Corrales S.M., Key M.L., Longo D.L. and Murphy W.J.: Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukoc. Biol. 59; 81-89, 1996.
29. Ishii N., Tada M., Sakuma S., Sawamura Y., Shinohe Y., and Abe H.: Human astrocytoma cells are capable of producing macrophage inflammatory protein-1β. J. Neuro-Oncol. 37; 17-23, 1998.
30. Burke F., Relf M., Negus R., and Balkwill F.: A cytokine profile of normal and malignant ovary. Cytokine 8; 578-585, 1996.
31. Warhurst A.C., Hopkins S.J., and Warurst J.: Interferon gamma induces differential upregulation of a and b chemokine secretion in colonic epithelial cell lines. Gut 42; 208-213, 1998.
32. Vainer B., Nielsen O.H., and Horn T.: Expression of E-selectin, sialyl Lewis X, and macrophage inflammatory protein-1alpha by colonic epithelial cells in ulcerative colitis. Dig. Dis. Sci. 43; 596-608, 1998.
33. Konishi T., Okabe H., Katoh H., Fujiyama Y., and Mori A.: Macrophage inflammatory protein-1 alpha expression in non-neoplastic and neoplastic lung tissue. Virchows Archiv. 428; 107-111, 1996.
34. Yamaoka Y., Kita M., Sawai N., Tanahashi T., Kashima K., and Imanishi J.: Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42; 609-617, 1998.
35. Japanese Research Society for Gastric Cancer, Japanese classification of gastric carcinoma. First English edition. Tokyo: Kanehara, 1995.
36. Youngs S.J., Ali S.A., Taub D.D., and Rees R.C.: Chemokines induce migrational responses in human breast carcinoma cell lines. Int. J. Cancer 71; 257-266, 1997.
37. Kaji M., Yonemura Y., Harada S., Liu X., Terada I., Yamamoto H.: Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Therapy 3; 393-404, 1996.
38. Inoue T., Chung Y.S., Yashiro M., Nishimura S., Hasuma T., Otani S., Sowa M.: Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jap. J. Cancer Res. 88; 152-9, 1997.
39. Niki M., Isozaki H., Toyoda M., Ishibashi T., Fujii K., Nomura E., Mabuchi H., Nakamura M., Nishiguchi K., Tanigawa N.: Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma. Hepato-Gastroenterology. 45; A2458-63, 1998.
40. Han S.U., Lee J.H., Kim W.H., Cho Y.K., Kim M.W.: Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J. Surgery 23; 1176-80, 1999.
41. Beppu K., Uchiyama A., Morisaki T., Nakamura K., Noshiro H., Matsumoto K., Nakamura T., Tanaka M., Katano M.: Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. Anticancer Research. 20; 1263-7, 2000.
42. Beppu K., Uchiyama A., Morisaki T., Matsumoto K., Nakamura T., Tanaka M., Katano M.: Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients. Anticancer Research. 21; 2195-200, 2001.
43. Opdenakker G. and Van Damme J.: Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol. Today 13; 363-364, 1992.
44. Opdenakker G. and Van Damme J.: Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 4; 251-258, 1992.
45. Stuve O., Chabot S., Jung S.S., Williams G., and Yong V.W.: Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J. Neuroimmunology 80; 38-46, 1997.
46. Johnatty R.N., Taub D.D., Reeder S.P., Turcovski-Corrales S.M., Cottam D.W., Stephenson T.J., and Rees R.C.: Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J. Immunol. 158; 2327-2333, 1997.
47. Himelstein B.P., Canete-Soler R., Bernhard E.J., Dilks D.W., and Muschel R.J.: Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion & Metastasis 14; 246-258, 1994.
48. Westermarck J. and Kahari V.M.: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13; 781-792, 1999.